RxDoctor Payments DataLook up a doctor →

John Novak, PA

Medical · Aurora, CONPI 1215198593

Payments from drug & device makers

$173,204in general payments, 2019–2025

Across 530 payments — averaging $326.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$56K
  • GSK$34K
  • AstraZeneca$32K
  • Gilead$25K
  • G1 Therapeutics, Inc.$11K
  • Hologic Sales And Service, LLC$3K
  • plus $12K from 29 others

What the payments were for

  • Consulting fees$10,9966%
  • Speaking & faculty fees$125,14272%
  • Travel & lodging$22,71313%
  • Food & beverage$13,7658%
  • Education$5890%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$173,204 in reported general payments places this provider in the 95th percentile of 766 medical providers in Colorado.

See all medical providers in Colorado

Medicare billing

Part B allowed, 2024
$32,110
Medicare patients
144
Services billed
309

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LynparzaOlaparib13$110,699
EliquisApixaban60$61,110
XareltoRivaroxaban41$41,551
Letrozole51$1,155
Anastrozole41$839
Gabapentin43$838
Hydroxyurea11$496
Prochlorperazine Maleate16$405
Dexamethasone12$401
Potassium Chloride25$350
Oxycodone Hcl20$260
Ondansetron Hcl12$237
Ondansetron OdtOndansetron14$229
Tramadol Hcl20$203
Citalopram HbrCitalopram Hydrobromide27$176

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaLynparza$31,570$110,69913 claims
PfizerEliquis$309$61,11060 claims
Johnson & JohnsonXarelto$99$41,55141 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 766 medical providers in Colorado.

Other medical in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →